Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Training in intralymphatic injection technique for grass allergy immunotherapy
2014-004031-40Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- Mar 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of alutard phleum pratense in allergic rhinoconjunctivitis (ARC) and allergic rhinitis (AR), sponsored by Aarhus University Hospital. Primary endpoint: Number of injections to achieve stable successful performance. Started Mar 2015; status: completed.
02
Drugs
alutard phleum pratense
03
Conditions
allergic rhinoconjunctivitis (ARC)allergic rhinitis (AR)
Beyond the preview
Go deeper on 2014-004031-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004031-40.